End-stage kidney disease (ESKD)

Clinical trials for End-stage kidney disease (ESKD) explained in plain language.

Never miss a new study

Get alerted when new End-stage kidney disease (ESKD) trials appear

Sign up with your email to follow new studies for End-stage kidney disease (ESKD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Not yet recruiting 4 Not yet finished but already full! 5 Completed 3

New drug aims to calm inflammation in kidney dialysis patients

Disease control Recruiting now

This early-stage trial tests a drug called CSL300 (clazakizumab) in 24 Chinese adults with end-stage kidney disease who are on dialysis. The drug is an antibody that blocks interleukin-6, a protein involved in inflammation. The main goal is to see how the drug moves through the b…

Matched conditions: END-STAGE KIDNEY DISEASE (ESKD)

Phase 1 • Sponsor: CSL Behring • Aim: Disease control

Last updated Jul 09, 2026 00:00 UTC

End-stage kidney disease (ESKD)

Get alerted when new End-stage kidney disease (ESKD) trials appear

New drug aims to calm inflammation in kidney dialysis patients